Jerusha Daggolu, MD

Department of Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, Houston, Texas

  • 2Articles
  • 2.7KReads
  • 2025–2026Active
  • 1Collaborators
  • 1Citations

About

Jerusha Daggolu, MD, is affiliated with the Department of Pharmaceutical Health Outcomes and Policy at the University of Houston College of Pharmacy. The author has published on topics related to weight management and schizophrenia/schizoaffective disorders, focusing on the use of metformin in patients receiving second-generation antipsychotics. Their work includes examining vitamin B12 deficiency risk during metformin treatment and the effects of concurrent metformin on treatment adherence and persistence in nondiabetic patients. Daggolu has collaborated frequently with Hua Chen and published in Psychiatrist.com between 2025 and 2026.

Publications

JCP
Vitamin B12 Deficiency Risk With Metformin for Weight Management in Second-Generation Antipsychotic Recipients: Reply to Mulsant et al
Letter to the Editor

Vitamin B12 Deficiency Risk With Metformin for Weight Management in Second-Generation Antipsychotic Recipients: Reply to Mulsant et al

March 18, 2026

Daggolu and Chen reply to a letter commenting on their study of metformin use in patients receiving second-generation antipsychotics.
,
JCP
Effect of Adjuvant Metformin on Adherence to and Persistence of Treatment With SGAs in Nondiabetic Patients
Original Research

Effect of Adjuvant Metformin on Adherence to and Persistence of Treatment With SGAs in Nondiabetic Patients

November 17, 2025

Use of metformin with second-generation antipsychotics (SGAs) was associated with improved adherence and persistence to SGAs at both 180- and 365-day follow-up in adults with Medicaid and commercial insurance.
,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe